Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
The American Journal of Tropical Medicine and Hygiene
|
November 29, 2021
A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana
Nicholas O Opoku, Michael E Gyasi, Felix Doe, et al.
JAMA Network Open
|
June 17, 2026
Initial Injury Type and Violent Reinjury
Nicholas Szoko, Daphne Lew, Taylor Kaser, et al.
The International Journal of Eating Disorders
|
April 16, 2026
Acceptability, Feasibility, and Preliminary Effectiveness of a Mobile App for Teens With or at High Risk for Eating Disorders: A Three-Arm Pilot Randomized Controlled Trial Comparing Self-Help, Guided Self-Help, and Guided Self-Help With a Social Networking Component
Patricia A Cavazos-Rehg, Ellen E Fitzsimmons-Craft, Erin Kasson, et al.
Plos Neglected Tropical Diseases
|
March 29, 2021
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia
Taniawati Supali, Yenny Djuardi, Michael Christian, et al.
Pediatric Obesity
|
June 7, 2023
Relationships examined: Parent and child readiness to change and sociodemographic characteristics in family based weight loss treatment
Melissa Ramel, Denise E Wilfley, Rachel Tabak, et al.
Plos Neglected Tropical Diseases
|
September 18, 2023
Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study
Catherine M Bjerum, Benjamin G Koudou, Allassane F Ouattara, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 6, 2021
Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire
Allassane F Ouattara, Catherine M Bjerum, Méité Aboulaye, et al.
JAMA
|
June 14, 2023
Family-Based Behavioral Treatment for Childhood Obesity Implemented in Pediatric Primary Care: A Randomized Clinical Trial
Leonard H Epstein, Denise E Wilfley, Colleen Kilanowski, et al.
ACR Open Rheumatology
|
March 4, 2025
Patient-Reported Social Risk Factor Screening Among Rheumatology Outpatients
Alissa Chandler, Mohammed Hamid, Ziqiao Jiao, et al.
Neuromuscular Disorders : NMD
|
March 11, 2026
A prospective, multi-center, observational study of the safety, tolerability and effectiveness of Nusinersen in adult patients with spinal muscular atrophy
Craig M Zaidman, Crystal Proud, Bing M Liao, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
The American Journal of Tropical Medicine and Hygiene
|
November 29, 2021
A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana
Nicholas O Opoku, Michael E Gyasi, Felix Doe, et al.
JAMA Network Open
|
June 17, 2026
Initial Injury Type and Violent Reinjury
Nicholas Szoko, Daphne Lew, Taylor Kaser, et al.
The International Journal of Eating Disorders
|
April 16, 2026
Acceptability, Feasibility, and Preliminary Effectiveness of a Mobile App for Teens With or at High Risk for Eating Disorders: A Three-Arm Pilot Randomized Controlled Trial Comparing Self-Help, Guided Self-Help, and Guided Self-Help With a Social Networking Component
Patricia A Cavazos-Rehg, Ellen E Fitzsimmons-Craft, Erin Kasson, et al.
Plos Neglected Tropical Diseases
|
March 29, 2021
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia
Taniawati Supali, Yenny Djuardi, Michael Christian, et al.
Pediatric Obesity
|
June 7, 2023
Relationships examined: Parent and child readiness to change and sociodemographic characteristics in family based weight loss treatment
Melissa Ramel, Denise E Wilfley, Rachel Tabak, et al.
Plos Neglected Tropical Diseases
|
September 18, 2023
Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study
Catherine M Bjerum, Benjamin G Koudou, Allassane F Ouattara, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 6, 2021
Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire
Allassane F Ouattara, Catherine M Bjerum, Méité Aboulaye, et al.
JAMA
|
June 14, 2023
Family-Based Behavioral Treatment for Childhood Obesity Implemented in Pediatric Primary Care: A Randomized Clinical Trial
Leonard H Epstein, Denise E Wilfley, Colleen Kilanowski, et al.
ACR Open Rheumatology
|
March 4, 2025
Patient-Reported Social Risk Factor Screening Among Rheumatology Outpatients
Alissa Chandler, Mohammed Hamid, Ziqiao Jiao, et al.
Neuromuscular Disorders : NMD
|
March 11, 2026
A prospective, multi-center, observational study of the safety, tolerability and effectiveness of Nusinersen in adult patients with spinal muscular atrophy
Craig M Zaidman, Crystal Proud, Bing M Liao, et al.
Page
of 8